After being diagnosed with kidney failure at 31, Sharron Rouse navigated years of uncertainty, dialysis, and ultimately a life-saving transplant before discovering her condition was caused by APOL1-mediated kidney disease, a genetic risk linked to African ancestry. Her journey from confusion and guilt to clarity and advocacy underscores the importance of genetic testing, personalized care, and awareness—especially for communities at higher risk.
Tag: APOL1 Gene
Posted inBaltimore News
Unlocking sickle cell mysteries: Dr. Ambroise Wonkam speaks on genetic modifiers and patient outcomes
Dr. Ambroise Wonkam, director of genetic medicine at Johns Hopkins, has dedicated his career to studying genetic variation in African populations and its impact on conditions like sickle cell disease. He explains how African-specific genetic modifiers could unlock new treatments, not just for sickle cell patients, but for improving healthcare globally.